Viewing Study NCT00483860


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-01-08 @ 12:22 PM
Study NCT ID: NCT00483860
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2007-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module